# DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

> **NCT05389774** · — · RECRUITING · sponsor: **Nottingham University Hospitals NHS Trust** · enrollment: 2000 (estimated)

## Conditions studied

- AI (Artificial Intelligence)
- Pulmonary Nodule, Solitary
- Pulmonary Nodule, Multiple
- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05389774
- **Lead sponsor:** Nottingham University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-23
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05389774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05389774, "DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05389774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*